Published in
Lippincott, Williams & Wilkins, Dermatitis, 3(33), p. e25-e29, 2021
DOI: 10.1097/der.0000000000000814
Links
Tools
Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Journal article published in 2021 by
Andrea Chiricozzi,
Lucia Di Nardo 
,
Marina Talamonti,
Marco Galluzzo,
Clara De Simone,
Gabriella Fabbrocini,
Angelo Valerio Marzano,
Giampiero Girolomoni,
Annamaria Offidani,
Maria Teresa Rossi,
Luca Bianchi,
Antonio Cristaudo,
Maria Teresa Fierro,
Luca Stingeni,
Giovanni Pellacani
and other authors.
,
Marina Talamonti,
Marco Galluzzo,
Clara De Simone,
Gabriella Fabbrocini,
Angelo Valerio Marzano,
Giampiero Girolomoni,
Annamaria Offidani,
Maria Teresa Rossi,
Luca Bianchi,
Antonio Cristaudo,
Maria Teresa Fierro,
Luca Stingeni,
Giovanni Pellacani
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 